Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis?

Scand J Infect Dis. 1994;26(5):545-51. doi: 10.3109/00365549409011812.

Abstract

52 children with severe cough persisting for more than 10 days were randomized to treatment with amoxycillin/clavulanic acid or placebo in a prospective double-blinded study. Clinically suspected cases of pertussis were excluded, yet 12 (23%) of the children had laboratory verified pertussis infection. The nasopharyngeal colonization showed a predominance of Moraxella catarrhalis which was isolated in 37 (71%) children. Streptococcus pneumoniae and Haemophilus influenzae were isolated in 11 (20%) and 16 (30%) children, respectively. The antibiotic-treated group had a significantly better recovery in both the pediatrician's estimation (p = 0.02) and the independent parental judgement (p = 0.002). These findings are consistent with the view that Moraxella catarrhalis could be directly involved in the pathogenesis of persistent cough in children.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Amoxicillin / therapeutic use
  • Amoxicillin-Potassium Clavulanate Combination
  • Child
  • Child, Preschool
  • Clavulanic Acids / therapeutic use
  • Cough / drug therapy
  • Cough / etiology*
  • Double-Blind Method
  • Drug Therapy, Combination / therapeutic use*
  • Female
  • Humans
  • Infant
  • Male
  • Moraxella catarrhalis / drug effects
  • Moraxella catarrhalis / isolation & purification*
  • Neisseriaceae Infections / drug therapy*
  • Neisseriaceae Infections / physiopathology
  • Prospective Studies
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / microbiology
  • Respiratory Tract Infections / physiopathology
  • Treatment Outcome
  • Whooping Cough / drug therapy

Substances

  • Clavulanic Acids
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin